QUOTED. 28 June 2019. Fulvio Renoldi.
Italian firm Bracco Imaging is building its precision medicine portfolio by buying molecular imaging company Blue Earth Diagnostics from UK venture capital firm Syncona Investment Management for $450m. See what Bracco's CEO Fulvio Renoldi said about it here.
"Blue Earth Diagnostics's innovative products and pipeline will significantly enhance Bracco Imaging's portfolio in precision medicine and personalized diagnostics, while expanding our range of nuclear oncology imaging solutions in the Urology segment and other specialties." – Fulvio Renoldi, CEO, Bracco
Click here for a free trial of Medtech Insight